Neuronal communication breakdown in neurotransmitter systems in Alzheimer's and Parkinson's dementias.
Chan-Palay
V
V
Neurology Clinic, University Hospital, Zürich, Switzerland.
D000109:Acetylcholine / Q000502:physiology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000473:pathology* / Q000503:physiopathology; D001921:Brain / Q000473:pathology* / Q000503:physiopathology; D002395:Catecholamines / Q000502:physiology; D002450:Cell Communication / Q000502:physiology; D003704:Dementia / Q000150:complications / Q000473:pathology* / Q000503:physiopathology; D005260:Female; D019004:Galanin; D006801:Humans; D008125:Locus Coeruleus / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009474:Neurons / Q000473:pathology* / Q000502:physiology; D009479:Neuropeptides / Q000502:physiology; D018377:Neurotransmitter Agents / Q000502:physiology*; D010300:Parkinson Disease / Q000150:complications / Q000473:pathology* / Q000503:physiopathology; D010455:Peptides / Q000502:physiology; D013377:Substantia Innominata / Q000473:pathology
D002395:Catecholamines; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D010455:Peptides; D019004:Galanin; D000109:Acetylcholine